Pinoxepin

Pinoxepin is a tricyclic antidepressant (TCA) that was developed in the 1970s. It is primarily used in the treatment of depression and anxiety disorders. Pinoxepin is known for its sedative properties, which make it useful in patients who have trouble sleeping due to their depressive symptoms.
Pharmacology[edit]
Pinoxepin works by inhibiting the reuptake of neurotransmitters such as serotonin and norepinephrine, thereby increasing their levels in the synaptic cleft and enhancing neurotransmission. This mechanism is similar to that of other TCAs, such as amitriptyline and imipramine.
Side Effects[edit]
Common side effects of Pinoxepin include dry mouth, constipation, urinary retention, and blurred vision. These are typical of the anticholinergic effects seen with many TCAs. Other side effects may include weight gain, drowsiness, and orthostatic hypotension.
Contraindications[edit]
Pinoxepin should not be used in patients with a history of myocardial infarction, arrhythmias, or severe liver disease. It is also contraindicated in patients who are currently taking monoamine oxidase inhibitors (MAOIs) due to the risk of serious drug interactions.
Interactions[edit]
Pinoxepin can interact with a variety of other medications, including antihypertensives, anticholinergics, and other central nervous system depressants. It is important to monitor patients for signs of increased side effects or toxicity when Pinoxepin is used in combination with these drugs.
Dosage[edit]
The dosage of Pinoxepin varies depending on the severity of the condition being treated and the patient's response to the medication. It is typically started at a low dose and gradually increased to minimize side effects.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian